Philips debuts Alice NightOne at-home sleep disorder diagnostic system
ANDOVER, Mass., June 4, 2015 /PRNewswire/ — Philips Respironics, a business of Royal Philips (NYSE: PHG AEX: PHIA), today unveiled Alice NightOne, an at home sleep testing system (HST)..
As the sleep lab industry adjusts to keep pace with the demands of value-based care and changing reimbursement requirements, Alice NightOne enables the efficient identification and treatment of sleep disorder patients. Fully compatible with the Philips Somnolyzer scoring solution, sleep technicians can read the results from the Alice NightOne HST and determine a sleep study score in 50-85 percent less time and with great accuracy*.
“Conventional laboratory-based sleep testing or polysomnography can pose challenges for sleep clinicians and patients, including limited availability and cost,” said Teofilo Lee-Chiong, M.D., Chief Medical Liaison, Philips. “This latest, intuitive testing option allows reliable and accurate diagnosis of sleep disordered breathing that is more accessible and efficient. More importantly, it gives patients the option of having a sleep testtest is test in the comfort of their own home, which may improve overall patient experience and drive better outcomes.”